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Deuterium and carbon-13 labelled glycerols have been fed to 
Streptomyces calvus fermentations and isotope incorporation into 
the fluorine containing antibiotic nucleocidin have been 10	  
evaluated by 19F-NMR. A single deuterium atom was 
incorporated from [2H5]- and (R)-[2H2]- glycerol into C-5’ of the 
antibiotic, suggesting that an oxidation occurs at this carbon 
after ribose ring assembly from glycerol (pentose phosphate 
pathway), during nucleocidin biosynthesis.   15	  
 
	  
Scheme 1.	    Fluorinase reaction of AdoMet 3 to give FDA 4 and then the 
relationship between FDA and FAc 1 and 4-FT 2. Incorporation of (R)-[2H2]-
glycerol determined that both fluoromethyl hydrogens at C5’of FDA 4 are 20	  
retained in the fluorometabolites.9 Nucleocidin 7 is a metabolite of  S. calvus. 
Fluorine containing natural products are exceedingly rare in nature.1 
The toxin fluoroacetate (FAc) 1 is the most widely distributed natural 
product of this class where it has been identified in many plants2 and 
a few bacteria.3,4 The mode of fluoroacetate biosynthesis in plants has 25	  
not been established, however its biosynthesis in bacteria is known.5 
Streptomyces cattleya is a bacterium that co-produces FAc 1 and 4-
fluorothreonine (4-FT) 2.3 Studies carried out with S. cattleya 
determined that the fluorination enzyme (fluorinase) catalyses a 
nucleophilic substitution reaction between fluoride ion and  S-30	  
adenosyl-L-methionine (Ado-Met) 3 to generate 5’-
fluorodeoxyadenosine (FDA) 4.6 This is the only biosynthetic 
fluorination enzyme known. It has subsequently been identified by 
gene mining in several other bacteria.7 FDA 4 is then processed to 
FAc 1 and 4-FT 2. A combination of isotopic labelling studies, 35	  
including isotopically labelled glycerol 5, and an understanding of the 
individual steps in the biosynthesis of 1 and 2 have determined that 
the C5’ fluoromethyl and C4’ carbon of FDA 4 are converted to FAc 
1 and C3 and C4 of 4-FT 2, the circled regions in Scheme 1.8 It has 
also been established that both hydrogens of the fluoromethyl group 40	  
of FDA 4 are retained in the conversion to the fluoromethyl groups of 
1 and 2.9  
The antibiotic nucleocidin 7 produced by the actinomycete soil 
bacterium, Streptomyces calvus is another example of the rare 
fluorometabolites.10 Its biosynthesis is unknown; however, the 45	  
presence of the fluorine atom at the C4’ position of the ribose ring11 
in 7 is inconsistent with the involvement of the fluorinase found in S. 
cattleya. Full genome sequencing of the nucleocidin producer S. 
calvus ATCC 13382 has not identified a fluorinase gene,12 thus S. 
calvus may employ a very different process for enzymatic C-F bond 50	  
formation relative to bacterial FAc 1 production. 
Ever since its isolation, from S. calvus in 1956,10 nucleocidin 7 
production has proved problematic, with consistently low titres and 
unpredictable production. Publically deposited strains appear to have 
lost the ability to produce nucleocidin.12-14 Some progress has been 55	  
made to understand the inconsistent production, and it has been 
observed that a mutation of the bldA gene, encoding a Leu-tRNA, is 
apparent in the publically available strains. Correction of this 
mutation was recently shown12 to re-establish production in S. calvus. 
In another study13 mutation of the rpoB gene (rifamycin resistance) 60	  
led to an apparent increase in nucleocidin production. In this study 
we use an in-house strain of S. calvus T-3018 held by Pfizer. This 
strain does not have a bldA mutation, although production is still 
fickle with very low titres. Nucleocidin production can however be 
monitored, even at low production levels, directly from extracts by 65	  
19F{1H}-NMR. As a first step towards elucidating the biosynthetic 
pathway to fluorometabolite 7 we now report the incorporation of 
various isotopically labelled glycerols 5 a-d.  
For this study we have supplemented fermentation cultures of S. 
calvus with glycerols [2-13C]- 5a, [2H5]- 5b, (R)-[2H1]- 5c and 70	  
(S)-[2H1]- 5d. Despite the low titres, we envisaged that the 
incorporation of deuterium or carbon-13 isotopes close to the fluorine 
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atom of the antibiotic could be reported visually by 19F{1H}-NMR 
due to heavy atom induced chemical shifts of the fluorine resonance, 
and/or 13C-19F-spin–spin coupling in the case of carbon-13 75	  
incorporation. 
A first experiment explored pulse feeding of glycerol [2-13C]- 5a to 
a final concentration of 8mM, in a shake flask fermentation of S. 
calvus. Cultures were worked up after 20 days as previously 
described.13 Nucleocidin is excreted from the bacterial cells and 80	  
thus the cells were spun down in a centrifuge and the supernatant 
was extracted into butanol. The extract was concentrated and was 
then analysed by 19F{1H}-NMR. The resultant spectrum is shown 
in Figure 1a. It is clear that the fluorine signal for nucleocidin has 
accompanying satellites due to 1JCF (232Hz) coupling, consistent 85	  
with a population (~25%) of nucleocidin 7 molecules enriched 
with carbon-13 at C4’. The satellite signals are off-centre relative 
to the natural abundance 19F-NMR signal due to a heavy atom α-
shift.8 This incorporation is entirely consistent with pentose 
phosphate pathway involvement in ribose biosynthesis where 90	  
carbons C3–C5 of D-ribose derive from the exogenously added 
glycerol, feeding into the C3 metabolite pool via sn-glycerol-3-
phosphate 6.15 
 
Figure 1. 19F{1H}NMR of nucleocidin 7 (-119.8ppm) after glycerol 5 95	  
feeding experiments to S. calvus fermentations. An unknown metabolite 
(-118.1ppm) is also present in some spectra. (a) [2-13C]-Glycerol 5a; (b) 
[2H5]-glycerol 5b; (c) (R)-[2H2]-glycerol 5c; (d) (S)-[2H2]-glycerol 5d.  A 
pictorial summary of the isotopic labelling outcome is given in each case. 
 100	  
Addition of perdeuterated glycerol 5b (final conc 8 mM) to a S. 
calvus fermentation led to the incorporation of deuterium (~5%) 
into nucleocidin 7 as determined by an upfield shift in the 
resultant {1H}19F-NMR spectrum as shown in Figure 1b. The 
magnitude of this upfield shift at 0.22ppm is consistent with a 105	  
single vicinal deuterium incorporated β- to the fluorine atom. 
There is a F-C-C-D  angular dependence on the magnitude of the 
shift ranging from 0.15ppm (0o) to 0.35ppm (180o) as determined 
in classic studies by Lambert and Greifenstein.16 The observed 
value is intermediate between these extremes and consistent with 110	  
a single vicinal C-D (γ-shift) bond approximately at 90o to the C-
F bond. This experiment does not however distinguish the 
location of the incorporation between C3’ or C5’ of the ribose 
ring of 7. To achieve such a distinction, comparative 
incorporation experiments were explored with the enantiomeric 115	  
glycerols (R)-[2H2]- 5c and (S)-[2H2]- 5d. It is already established 
that the pro-R arm of glycerol delivers C5’ of ribose through the 
pentose phosphate pathway, and that the pro-S arm delivers C3’ 
of ribose. Glycerols 5c and 5d were prepared synthetically with 
enantiomeric purities > 95% e.e., as previously described.9 The 120	  
resultant 19F{1H}-NMR spectra from each of these glycerol 
feeding experiments are shown in Figure 1c and Figure 1d. It is 
clear that only glycerol (R)-[2H2]- 5c results in the incorporation 
(~8%)  of deuterium into nucleocidin 7, and again only a single 
deuterium atom survives from the double labelled precursor. It 125	  
follows from the known stereochemistry of glycerol processing 
through the pentose phosphate pathway, that this deuterium is 
located at C5’.15,17   
In this experiment a second fluorometabolite was observed in the 
19F{1H}-NMR spectrum with a signal at -118.1ppm. This 130	  
metabolite is detected periodically in nucleocidin extracts 
although its occurrence and level is unpredictable in our 
experience. Such a fluoro metabolite was also observed in the 
recent study where nucleocidin production was elicited by 
reversing the bldA mutation.12   Its structure is unknown although 135	  
given the similar level of deuterium incorporation from glycerol 
5c, it appears to be metabolically related to nucleocidin either as a 
biosynthetic precursor, or as a metabolite. 
For isomer (S)-[2H2]- 5d the absence of any deuterium at C3’ in 7 
is consistent with sn-glycerol-3-phosphate 6 being processed to 140	  
ribulose-5-phosphate via xylulose-5-phosphate, and the action of 
D-ribulose-5-phosphate 3-epimerase, with exchange of the 
surviving deuterium with bulk solvent.18 The predicted labelling 




Scheme 2.	   The pentose phosphate pathway showing the fate of glycerol 
through to ribose-5-phosphate. Glycerol 5e has a virtual labelling pattern 
which is a composite of the experimentally administered glycerols 5a-d, and 150	  
also highlights the stereochemical fate of the (pro-R) hydroxymethyl carbon 
(■). This pathway predicts incorporation of a C3 glycerol unit (bold C-C bonds) 
into C-3-C-5 of ribose-5-phosphate, with the retention of two deuteriums at C-
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The outcome where both 5b and 5c glycerols contribute only one 
deuterium to C5’ of nucleocidin can be contrasted with the 
biosynthesis of FAc, 1 and 4-FT, 2 in S. cattleya discussed above 
and shown in Scheme 1. In those cases two deuterium atoms were 160	  
incorporated into the fluorometabolites, and by implication into 
the C5’ ribose carbon of FDA 4.9a For nucleocidin only one 
deuterium is incorporated.  
In summary, this study provides the first biosynthetic data on 
nucleocidin 7 assembly from isotope labelling studies. It is shown 165	  
that glycerol is incorporated into the ribose ring moiety of 
nucleocidin, consistent with expectation via the pentose 
phosphate pathway. However, the presence of a single deuterium 
only at the C5’ position of nucleocidin 7 after feeding 
experiments with glycerols 5b and 5c suggests that a hydrogen is 170	  
lost from this carbon after ribose ring assembly but prior to, or 
concominant with, fluorine introduction. This observation places 
a constraint on working hypotheses addressing nucleocidin 
biosynthesis.  
 175	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